Beurs gesloten -
London S.E.
15:31:49 12-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
34,01
USD
|
+7,19%
|
|
-4,17%
|
-5,26%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
267.779
|
264.244
|
306.810
|
259.166
|
197.073
|
201.504
|
-
|
-
|
Bedrijfswaarde
1 |
270.284
|
266.126
|
324.977
|
274.750
|
215.772
|
215.594
|
210.506
|
204.535
|
K/w-verhouding
|
20,1
x
|
18,7
x
|
23,4
x
|
18,9
x
|
17,1
x
|
14,7
x
|
13,3
x
|
12,3
x
|
Dividendrendement
|
2,87%
|
2,94%
|
2,45%
|
3,27%
|
3,93%
|
3,92%
|
4,03%
|
4,14%
|
Marktkapitalisatie/omzet
|
4,36
x
|
4,53
x
|
4,89
x
|
4,1
x
|
3,36
x
|
3,32
x
|
3,15
x
|
3,02
x
|
Bedrijfswaarde/omzet
|
4,4
x
|
4,56
x
|
5,17
x
|
4,34
x
|
3,67
x
|
3,56
x
|
3,29
x
|
3,07
x
|
Bedrijfswaarde/EBITDA
|
10,6
x
|
11
x
|
13,2
x
|
11
x
|
9,82
x
|
9,45
x
|
8,55
x
|
7,91
x
|
Bedrijfswaarde/FCF
|
16,1
x
|
24,3
x
|
20,7
x
|
21,1
x
|
19,1
x
|
16
x
|
14,3
x
|
13,3
x
|
FCF Yield
|
6,2%
|
4,11%
|
4,83%
|
4,75%
|
5,23%
|
6,26%
|
6,98%
|
7,52%
|
Price to Book
|
8,28
x
|
7,27
x
|
13,2
x
|
8,29
x
|
5,91
x
|
5,67
x
|
4,74
x
|
4,01
x
|
Aantal aandelen (in duizenden)
|
856.061
|
854.642
|
800.952
|
854.579
|
798.652
|
797.242
|
-
|
-
|
Referentieprijs
2 |
314,0
|
309,0
|
379,1
|
290,5
|
244,5
|
249,5
|
249,5
|
249,5
|
Datum van publicatie
|
30/01/20
|
4/02/21
|
3/02/22
|
2/02/23
|
1/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
61.466
|
58.323
|
62.801
|
63.281
|
58.716
|
60.610
|
63.999
|
66.718
|
EBITDA
1 |
25.419
|
24.281
|
24.692
|
25.015
|
21.976
|
22.813
|
24.607
|
25.859
|
Bedrijfsresultaat (EBIT)
1 |
22.479
|
21.536
|
21.897
|
22.173
|
19.240
|
20.129
|
21.875
|
22.970
|
Operationele Marge
|
36,57%
|
36,93%
|
34,87%
|
35,04%
|
32,77%
|
33,21%
|
34,18%
|
34,43%
|
Resultaat voor belastingen (EBT)
1 |
16.614
|
17.965
|
17.398
|
16.327
|
14.079
|
17.746
|
19.651
|
20.829
|
Nettowinst (verlies)
1 |
13.497
|
14.295
|
13.930
|
12.421
|
11.498
|
13.251
|
14.757
|
15.789
|
Nettomarge
|
21,96%
|
24,51%
|
22,18%
|
19,63%
|
19,58%
|
21,86%
|
23,06%
|
23,66%
|
WPA
2 |
15,62
|
16,52
|
16,20
|
15,37
|
14,31
|
16,96
|
18,79
|
20,31
|
Free Cash Flow
1 |
16.764
|
10.943
|
15.691
|
13.041
|
11.288
|
13.500
|
14.699
|
15.387
|
FCF-marge
|
27,27%
|
18,76%
|
24,99%
|
20,61%
|
19,22%
|
22,27%
|
22,97%
|
23,06%
|
Kasstroomconversie (ebitda)
|
65,95%
|
45,07%
|
63,55%
|
52,13%
|
51,37%
|
59,18%
|
59,74%
|
59,5%
|
Kasstroomconversie (nettowinst)
|
124,21%
|
76,55%
|
112,64%
|
104,99%
|
98,17%
|
101,88%
|
99,61%
|
97,46%
|
Dividend per aandeel
2 |
9,000
|
9,100
|
9,300
|
9,500
|
9,600
|
9,787
|
10,06
|
10,32
|
Datum van publicatie
|
30/01/20
|
4/02/21
|
3/02/22
|
2/02/23
|
1/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 S1
|
2025 S2
|
---|
Omzet
1 |
30.997
|
29.281
|
29.042
|
30.713
|
15.971
|
16.117
|
32.088
|
16.445
|
15.850
|
32.295
|
14.742
|
16.244
|
30.986
|
15.322
|
14.457
|
29.779
|
14.274
|
28.937
|
14.399
|
14.540
|
29.770
|
14.690
|
15.015
|
30.770
|
15.320
|
30.630
|
30.615
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
|
10.116
|
11.766
|
9.770
|
11.652
|
-
|
-
|
10.245
|
-
|
-
|
12.668
|
-
|
-
|
9.505
|
-
|
-
|
10.911
|
-
|
8.329
|
-
|
-
|
10.770
|
-
|
-
|
9.625
|
-
|
-
|
-
|
Operationele Marge
|
32,64%
|
40,18%
|
33,64%
|
37,94%
|
-
|
-
|
31,93%
|
-
|
-
|
39,23%
|
-
|
-
|
30,68%
|
-
|
-
|
36,64%
|
-
|
28,78%
|
-
|
-
|
36,18%
|
-
|
-
|
31,28%
|
-
|
-
|
-
|
Resultaat voor belastingen (EBT)
|
6.260
|
10.181
|
7.784
|
9.887
|
-
|
-
|
7.511
|
-
|
-
|
10.985
|
-
|
-
|
5.342
|
-
|
-
|
9.174
|
-
|
4.905
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettowinst (verlies)
|
4.878
|
8.079
|
6.216
|
7.803
|
-
|
-
|
6.127
|
-
|
-
|
8.530
|
-
|
-
|
3.891
|
-
|
-
|
7.137
|
-
|
4.361
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettomarge
|
15,74%
|
27,59%
|
21,4%
|
25,41%
|
-
|
-
|
19,09%
|
-
|
-
|
26,41%
|
-
|
-
|
12,56%
|
-
|
-
|
23,97%
|
-
|
15,07%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
WPA
|
5,630
|
9,320
|
7,200
|
9,050
|
-
|
-
|
7,150
|
-
|
-
|
10,54
|
-
|
-
|
4,830
|
-
|
-
|
8,870
|
-
|
5,440
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
30/01/20
|
23/07/20
|
4/02/21
|
22/07/21
|
20/10/21
|
3/02/22
|
3/02/22
|
25/04/22
|
21/07/22
|
21/07/22
|
18/10/22
|
2/02/23
|
2/02/23
|
27/04/23
|
27/07/23
|
27/07/23
|
1/11/23
|
1/02/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
2.505
|
1.882
|
18.167
|
15.584
|
18.699
|
14.089
|
9.002
|
3.031
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
0,0985
x
|
0,0775
x
|
0,7357
x
|
0,623
x
|
0,8509
x
|
0,6176
x
|
0,3658
x
|
0,1172
x
|
Free Cash Flow
1 |
16.764
|
10.943
|
15.691
|
13.041
|
11.288
|
13.500
|
14.699
|
15.387
|
ROE (netto-inkomsten/eigen vermogen)
|
57,7%
|
48%
|
56%
|
62,5%
|
45,7%
|
43,7%
|
40,5%
|
36,4%
|
ROA (netto-inkomsten/totale activa)
|
21,6%
|
19,6%
|
19,1%
|
18,2%
|
16,7%
|
14,6%
|
14,9%
|
14,7%
|
Totale activa
1 |
62.621
|
72.966
|
72.951
|
68.337
|
68.793
|
90.910
|
98.817
|
107.716
|
Nettoactief per aandeel
2 |
37,90
|
42,50
|
28,80
|
35,00
|
41,40
|
44,00
|
52,60
|
62,30
|
Cashflow per aandeel
2 |
25,90
|
21,50
|
24,40
|
22,80
|
20,00
|
20,10
|
21,50
|
23,70
|
Capex
1 |
3.503
|
3.528
|
3.693
|
3.449
|
3.742
|
3.742
|
3.922
|
4.083
|
Capex/omzet
|
5,7%
|
6,05%
|
5,88%
|
5,45%
|
6,37%
|
6,17%
|
6,13%
|
6,12%
|
Datum van publicatie
|
30/01/20
|
4/02/21
|
3/02/22
|
2/02/23
|
1/02/24
|
-
|
-
|
-
|
Laatste slotkoers
249,5
CHF Gemiddelde koersdoel
278,1
CHF Spread / Gemiddelde doel +11,44% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +55,32% | 815 mld. | | -6,75% | 352 mld. | | +13,56% | 314 mld. | | +10,68% | 303 mld. | | +16,57% | 242 mld. | | +13,31% | 218 mld. | | +8,48% | 168 mld. | | -2,81% | 159 mld. | | +0,20% | 120 mld. |
Farmaceutische producten - Andere
|